Thanks to Reviewers.
- Published in:
- Medical Mycology, 2022, v. 60, n. 5, p. 1, doi. 10.1093/mmy/myac023
- Publication type:
- Article
Works matching IS 13693786 AND DT 2022 AND VI 60 AND IP 5
Results: 7
1
2
Can Beta-D-Glucan testing as part of the diagnostic pathway for invasive fungal infection reduce anti-fungal treatment costs?
- Published in:
- Medical Mycology, 2022, v. 60, n. 5, p. 1, doi. 10.1093/mmy/myac034
- By:
- Publication type:
- Article
3
Investigation of the value of precipitins in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with a positive marker for Aspergillus species.
- Published in:
- Medical Mycology, 2022, v. 60, n. 5, p. 1, doi. 10.1093/mmy/myac031
- By:
- Publication type:
- Article
4
Cationic lipid-based formulations for encapsulation and delivery of anti-EFG1 2′ OMethylRNA oligomer.
- Published in:
- Medical Mycology, 2022, v. 60, n. 5, p. 1, doi. 10.1093/mmy/myac030
- By:
- Publication type:
- Article
5
Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern.
- Published in:
- Medical Mycology, 2022, v. 60, n. 5, p. 1, doi. 10.1093/mmy/myac029
- By:
- Publication type:
- Article
6
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections.
- Published in:
- Medical Mycology, 2022, v. 60, n. 5, p. 1, doi. 10.1093/mmy/myac028
- By:
- Publication type:
- Article
7
Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
- Published in:
- Medical Mycology, 2022, v. 60, n. 5, p. 1, doi. 10.1093/mmy/myac026
- By:
- Publication type:
- Article